# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-014623
Filing Date
2019-03-18
Accepted
2019-03-18 16:13:45
Documents
85
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | tv515695-10k.htm | 10-K | 1457088
2 | EXHIBIT 3.2 | tv515695_ex3-2.htm | EX-3.2 | 92861
3 | EXHIBIT 10.18 | tv515695_ex10-18.htm | EX-10.18 | 242885
4 | EXHIBIT 21 | tv515695-exh21.htm | EX-21 | 1691
5 | EXHIBIT 23.1 | tv515695-exh23x1.htm | EX-23.1 | 2131
6 | EXHIBIT 31.1 | tv515695-exh31x1.htm | EX-31.1 | 10001
7 | EXHIBIT 31.2 | tv515695-exh31x2.htm | EX-31.2 | 10012
8 | EXHIBIT 32 | tv515695-exh32.htm | EX-32 | 5145
15 | GRAPHIC | tv515695_chrt-line1.jpg | GRAPHIC | 106182
16 | GRAPHIC | tv515695_chrt-line2.jpg | GRAPHIC | 177140
17 | GRAPHIC | tv515695_chrt-pipline.jpg | GRAPHIC | 236953
18 | GRAPHIC | tv515695_img1.jpg | GRAPHIC | 250925
| Complete submission text file | 0001144204-19-014623.txt |  | 12202345

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE DOCUMENT | abeo-20181231.xml | EX-101.INS | 3621980
10 | XBRL TAXONOMY EXTENSION SCHEMA | abeo-20181231.xsd | EX-101.SCH | 43371
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | abeo-20181231_cal.xml | EX-101.CAL | 45385
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | abeo-20181231_def.xml | EX-101.DEF | 336579
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | abeo-20181231_lab.xml | EX-101.LAB | 352745
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | abeo-20181231_pre.xml | EX-101.PRE | 394669

Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 19688355
SIC: 2834 Pharmaceutical Preparations